The notable new material in this 2025-26 edition includes the following: Section 3.2.2
GHK-Cu exhibits additional anti-inflammatory activity even when STAT3 is silenced, indicating that it also influences other anti-inflammatory pathways [1]
All our products are manufactured in FSSAI-certified facilities, following strict quality and food safety standards
Pol J Radiol
Seven additional Phase 3 readouts expected through 2026: TRIUMPH-1 (obesity), TRIUMPH-2 (obesity + diabetes), TRIUMPH-3 (obesity + cardiovascular risk), SELECT-M (MASH), SLEEP (OSA), BACK PAIN, and a cardiovascular/renal outcomes readout
Quantification and statistical analysis Qualitative data were shown as frequency with percentage, while quantitative data were shown as median with interquartile range